Saturday, September 23, 2023

Allergy Immunotherapy Market Set to Reach a Valuation of US$ 4.07 Billion by 2033, Fueled by Global Allergy Prevalence Surge | Future Market Insights Inc.

Last updated Wednesday, September 13, 2023 12:35 ET , Source: Future Market Insights, Inc.

Newark, United States, 09/13/2023 / Future Market Insights, Inc. /

According to FMI, the global allergy immunotherapy market could be worth US$ 1.74 billion in 2023. The market is expected to reach US$ 4.07 billion by 2033, growing at an 8.9% CAGR between 2023 and 2033.

In the United States, around 15 million people have food allergies, of which 4% are children and more than 60% are adults, as per FARE (Food Allergy Research & Association). Allergies are when the body’s immune system becomes oversensitive to certain things, such as certain foods, pollen, fur, or dust. Food, dust, pollen, latex, medicines, and other things can cause allergies, to name a few.

By exposing the body to allergens in minute amounts so that antibodies can build against the allergens, allergy immunotherapy is a method of treating allergies. Immunotherapy involves repeatedly exposing patients to specific allergens and in tiny doses, which trains the body to tolerate their presence and promotes effective and prompt allergy treatment.

Request a Sample Report Today to get Premium Insights:


The predicted revenue growth could be related to the burden of allergy conditions, which are becoming more prevalent globally. The responsibility that complex allergies with increased morbidity place on the healthcare system motivates research and development in this area for the introduction of innovative medicines.

The primary factors propelling the global market are:

  • The expansion of industrialization and population.
  • Improvements in healthcare and medicine.
  • The launch of novel immunotherapeutic medications.

Current regulatory approvals, such as those for oral dissolvable tablets, are further enhanced to gain a larger global allergy immunotherapy market share.

Compared to other treatments already on the market, sublingual allergy immunotherapy has been clinically shown to be more effective and have fewer adverse effects. Another factor influencing the allergy immunotherapy market growth is the demographic shift in the population and the macroeconomic environment.

The prevalence of asthma and allergy respiratory illnesses has increased due to rising air pollution levels inside and outside. According to the Asthma and Allergy Association of America (AAFA), rising pollen levels cause more than 25 million allergies.

Europe and North America are the two leading markets for allergy immunotherapy, and they are likely to continue holding a sizable market share during the forecast period. Given the increased awareness, healthcare reimbursement regulations, and growth in the population who suffer from allergies, Europe is estimated to hold a significant portion of the global allergy immunotherapy market.

“Allergy immunotherapy represents a transformative approach to allergy treatment. This therapeutic method offers long-term relief by desensitizing the immune system to allergens, fundamentally changing how we manage allergies and providing hope for sufferers worldwide.”—by Lead Analyst at Future Market Insights.


  • The market in the United Kingdom is anticipated to rise, exhibiting a CAGR of 9.1% through 2033.
  • The United States is expected to develop at a 9.1% CAGR during the forecast period.
  • With a CAGR of 9.3% over the forecast period, Canada is predicted to grow rapidly in the market.
  • The market in China is expected to increase, registering a CAGR of 8.8% over the forecast period.
  • Germany is estimated to grow decently, registering a CAGR of 9.7% until 2033.

Buy Now! Gain exclusive insights and secure your edge in the allergy immunotherapy market: https://www.futuremarketinsights.com/checkout/9043


Top players operating in the allergy immunotherapy market are ALK Abello, Stallergenes Greer, Allergy Therapeutics, Aimmune Therapeutics, Anergis, Arrayit Corporation, Biomay AG, HAL Allergy Group, DBV Technologies, and others.

These key players in the market are developing innovative products, such as sublingual and subcutaneous immunotherapy, to cater to the growing demand for effective allergy treatments. They also invest in research and development to improve existing therapies’ efficacy and safety and expand their market reach through strategic partnerships and collaborations.


  • In September 2021, ALK confirmed that by expanding the number of patients by at least 100,000 yearly, it intends to make allergy testing, immunotherapy treatments, and adrenaline products accessible by 2030.
  • In June 2021, with the complete restoration of SCIT manufacturing in Antony, Stallergenes Greer declared that Alustal®, its subcutaneous allergen immunotherapy (SCIT) remedy, is now accessible in Italy and Spain.

Allergy Immunotherapy Market Segmentation:


  • SLIT Tablets
    • Odactra
    • Grastek
    • Ragwitek
    • Oralair
    • Actair
    • Others
  • Oral
    • Palforzia
    • Others
  • Injections
  • Others


  • Sublingual Immunotherapy
  • Subcutaneous Immunotherapy
    • Specific Immunotherapy
  • Others


  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis
  • Others


  • Pollens
    • Grass Pollens
    • Weed Pollens
    • Tree Pollens
  • House Dust Mites
  • Mold
  • Animal Dander
  • Bee Venom
  • Cockroaches/Insects
  • Others

Distribution Channel:

  • Institutional Sales
    • Government Hospitals
    • Semi-Government Hospitals
    • Private Hospitals
  • Retail Sales
    • Retail Pharmacy
    • Drug Stores
    • Online Pharmacy

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:

Allergy Treatment Market Analysis: The allergy treatment market is likely to secure a CAGR of 6.9% during the forecast period. The market is estimated to be valued at US$ 20.20 Billion in 2022 and is likely to reach figures of US$ 38.9 Billion by 2032.

Birch Allergy Treatment Market Trends: The global birch allergy treatment market garnered a market value of US$ 571 Million in 2023 and is expected to accumulate a market value of US$ 1123.24 Million by registering a CAGR of 7% in the forecast period 2023 to 2033.

Healthcare Regulatory Affairs Outsourcing Market Growth: The healthcare regulatory affairs outsourcing market is expected to grow at a CAGR of 11.3% during the forecast period. The market is valued at US$ 2 billion as of 2023, and by 2033, the market is expected to hit a valuation of US$ 5.8 billion.

About Future Market Insights (FMI) 

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: [email protected]

Website: https://www.futuremarketinsights.com

LinkedInTwitterBlogs | YouTube

The post Allergy Immunotherapy Market Set to Reach a Valuation of US$ 4.07 Billion by 2033, Fueled by Global Allergy Prevalence Surge | Future Market Insights Inc. appeared first on Future Market Insights.

Original Source of the original story >> Allergy Immunotherapy Market Set to Reach a Valuation of US$ 4.07 Billion by 2033, Fueled by Global Allergy Prevalence Surge | Future Market Insights Inc.